Stockscreener 앱 받기
75.65
1.12%
0.84
시장 영업 전:
76.30
0.65
+0.86%
전일 마감가:
$74.81
열려 있는:
$75
하루 거래량:
4.09M
Relative Volume:
0.95
시가총액:
$31.26B
수익:
$9.51B
순이익/손실:
$2.64B
주가수익비율:
12.53
EPS:
6.0361
순현금흐름:
$2.14B
1주 성능:
+6.06%
1개월 성능:
+3.67%
6개월 성능:
-37.00%
1년 성능:
-46.82%
1일 변동 폭
$0.00
$0.00
1주일 범위
$71.11
$75.69
52주 변동 폭
$68.77
$148.30
조에티스 Stock (ZTS) Company Profile
명칭
Zoetis Inc
전화
973-822-7000
주소
10 SYLVAN WAY, PARSIPPANY, NJ
Compare ZTS vs TAK, TEVA, HLN, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZTS
Zoetis Inc
|
75.65 | 31.26B | 9.51B | 2.64B | 2.14B | 6.0361 |
TAK
Takeda Pharmaceutical Co Adr
|
18.68 | 59.67B | 29.91B | 1.30B | 3.49B | 0.4056 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
41.17 | 48.02B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.50 | 41.78B | 14.54B | 2.22B | 2.58B | 0.4871 |
UTHR
United Therapeutics Corp
|
550.10 | 23.59B | 3.17B | 1.29B | 1.01B | 27.09 |
조에티스 Stock (ZTS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-06 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2026-05-27 | 다운그레이드 | Argus | Buy → Hold |
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-12-15 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-12-09 | 개시 | Barclays | Equal Weight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Sector Weight |
| 2025-07-17 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-06-18 | 다운그레이드 | Stifel | Buy → Hold |
| 2024-12-02 | 개시 | Leerink Partners | Outperform |
| 2024-07-25 | 개시 | BTIG Research | Buy |
| 2024-01-12 | 재확인 | Stifel | Buy |
| 2023-12-19 | 재개 | Jefferies | Buy |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-09-06 | 개시 | HSBC Securities | Buy |
| 2022-07-12 | 개시 | Piper Sandler | Overweight |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-07-16 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2021-03-08 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2021-03-08 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-09-21 | 개시 | Atlantic Equities | Overweight |
| 2020-08-14 | 업그레이드 | Edward Jones | Hold → Buy |
| 2020-08-12 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2020-05-27 | 개시 | Jefferies | Buy |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-09-09 | 개시 | Goldman | Buy |
| 2019-07-01 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-06-11 | 개시 | Barclays | Overweight |
| 2019-05-23 | 개시 | Guggenheim | Buy |
| 2019-05-03 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-03-20 | 개시 | SunTrust | Hold |
| 2019-03-04 | 업그레이드 | Stifel | Hold → Buy |
| 2019-01-23 | 개시 | UBS | Neutral |
| 2018-10-15 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2018-08-22 | 다운그레이드 | Stifel | Buy → Hold |
| 2018-08-03 | 재확인 | Stifel | Buy |
| 2018-04-19 | 재확인 | Citigroup | Buy |
| 2018-03-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2018-02-16 | 재확인 | Stifel | Buy |
| 2018-01-04 | 업그레이드 | Citigroup | Neutral → Buy |
모두보기
조에티스 주식(ZTS)의 최신 뉴스
Zoetis (ZTS) Outpaces Stock Market Gains: What You Should Know - Zacks Investment Research
Is it the Right Time to Add Phibro Stock to Your Portfolio? - Zacks Investment Research
Zoetis' Simparica Trio Shows Superior Heartworm Protection; ZTS Dividend Remains Attractive - GuruFocus
Zoetis Reports Q2 2026 Results: Full Earnings Call Transcript - Benzinga
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis (CEUX:ZOED) Change In Prepaid Assets : €0.00 Mil (TTM As of Jun. 2026) - GuruFocus
Vietnam Veterinary Vaccine Import Market and Top 10 Importers Guide 2023-2026 | Import Reliance and Aquaculture Growth Create Market Entry Opportunities - GlobeNewswire Inc.
Zoetis (ZTS) Has a Huge Animal Health Moat. Is It Starting to Crack? - Yahoo Finance
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why - Zacks Investment Research
Zoetis (ZTS) Stock Sinks As Market Gains: Here's Why - Yahoo Finance
Zoetis Inc. stock underperforms Thursday when compared to competitors - marketwatch.com
US98978VAX1 Bond Profile: Coupon and Redemption - TradingView
Zoetis stock hits 52-week low at $69.48 - Investing.com
Join Class Action to Recover Losses from Zoetis Inc. (ZTS) – Contact Levi & Korsinsky Before July 27, 2026 - ACCESS Newswire
PFE4666688 Bond Profile: Coupon and Redemption - TradingView
Zoetis shares drop 71% since 2021 but remain a buy with strong margins and pipeline potential. - Pluang
Zoetis: Priced For The Worst, Worth Buying (NYSE:ZTS) - Seeking Alpha
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
PFE4538720 Bond Profile: Coupon and Redemption - TradingView
Zoetis Adds Equine Hematology Capabilities to Vetscan OptiCell and Vetscan Imagyst - myvetcandy.com
Veterinary Diagnostics Market Size to Soar to USD 30.78 Billion by 2035 at a CAGR of 10.1%SNS Insider - GlobeNewswire Inc.
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
Zoetis (ZTS) Registers a Bigger Fall Than the Market: Important Facts to Note - Yahoo Finance
Zoetis Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Zoetis to Host Webcast and Conference Call on Third Quarter 2026 Financial Results - Business Wire
Zoetis Inc. stock outperforms competitors despite losses on the day - MarketWatch
Zoetis (ZTS) Stock Drops Despite Market Gains: Important Facts to Note - Yahoo Finance
Zoetis Stands by Guidance as Pet-Care Weakness and Competition Pressure Sales - Yahoo Finance
Michael Burry Sells FLUT To Pile Into LULU Under $100 — Plus A New Bet On ZTS - TradingView
Why Are Zoetis (NYSE:ZTS) Diagnostics in S&P 500 Focus? - Kalkine Media
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? - Yahoo Finance
Pfizer Stock Or Zoetis: Is The Comeback Worth Paying Up For? - Trefis
Zoetis Shares Slide Following Earnings RevisionEarnings Deceleration Risk - vinanet.vn
Zoetis Stock (ZTS) Opinions on Michael Burry Portfolio Update - Moomoo
Zoetis Stock (ZTS) Opinions on Michael Burry Portfolio Update - Quiver Quantitative
Zoetis Taps Former GE HealthCare CFO Jay Saccaro as CFO and COO - The Healthcare Technology Report.
Zoetis Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Paws and profits: Zoetis appoints global diagnostics president, NVA names chief medical officer, and more updates - DVM360
Zoetis (ZTS) Shares Drop After Earnings Revision - Yahoo Finance
Veterinary Diagnostic Markets Report Now Available — See Exactly How IDEXX, Zoetis, Antech, Roche, and Thermo Fisher Are Positioned to Win Through 2030 - GlobeNewswire Inc.
Zoetis Inc. (ZTS) Investor Outlook: Unlocking a 26.63% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews
Is Zoetis Stock Underperforming the S&P 500? - Yahoo Finance
Zoetis Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - BioSpace
Zoetis to Participate in the Morgan Stanley 24th Annual Global Healthcare Conference - Business Wire
Zoetis (NYSE:ZTS) Offers Value and Quality in One Attractive Package - ChartMill
Zoetis Inc. (ZTS) - DirectorsTalk Interviews
Zoetis Inc. stock outperforms competitors on strong trading day - MarketWatch
조에티스 (ZTS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
조에티스 주식 (ZTS) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Bisaro Paul | Director |
May 13 '26 |
Buy |
75.88 |
2,000 |
151,750 |
27,862 |
| MCCALLISTER MICHAEL B | Director |
May 11 '26 |
Buy |
77.76 |
3,000 |
233,273 |
24,524 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Option Exercise |
41.83 |
20,000 |
836,600 |
121,337 |
| PECK KRISTIN C | Chief Executive Officer |
Feb 17 '26 |
Sale |
127.05 |
20,000 |
2,540,964 |
101,337 |
| Polzer Robert J | Officer |
Feb 17 '26 |
Proposed Sale |
127.34 |
2,346 |
298,742 |
0 |
| PECK KRISTIN C | Officer |
Feb 17 '26 |
Proposed Sale |
127.05 |
20,000 |
2,540,964 |
0 |
| Polzer Robert J | Officer |
Feb 13 '26 |
Proposed Sale |
129.09 |
3,662 |
472,728 |
0 |
0.17%
0.57%
자본화:
|
볼륨(24시간):